| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ITSA4
|
13.10 | 146.9B | 8.65 | 1.63 | 7.79 | — | — | 71 | 48 | 15.24 | +11.8% | 89 | 0.13 |
|
BBDC4
|
17.19 | 181.7B | 7.82 | 1.01 | — | — | — | 70 | 42 | 25.56 | +31.2% | 88 | 2.59 |
|
ITUB4
|
39.52 | 435.6B | 9.47 | 2.08 | — | — | — | 69 | 54 | 41.01 | +2.6% | 100 | 2.67 |
|
BBAS3
|
20.74 | 118.4B | 9.35 | 0.62 | — | — | — | 63 | 26 | 33.74 | +40.1% | 75 | 2.04 |
|
BBSE3
|
40.40 | 78.4B | 8.58 | 6.20 | — | — | — | 59 | 50 | 27.17 | -22.6% | 100 | 0.00 |
|
B3SA3
|
16.22 | 81.1B | 16.36 | 4.44 | 9.31 | — | — | 49 | 43 | 9.26 | -32.2% | 79 | 0.85 |
|
SANB11
|
29.56 | 221.3B | 18.35 | 1.75 | — | — | — | 48 | 25 | 22.48 | -15.3% | 87 | 0.23 |
|
BPAC11
|
54.71 | 634.0B | 36.63 | 8.51 | — | — | — | 45 | 28 | 15.18 | -49.8% | 100 | 1.00 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.